Is this you? Create Your Porfile
Avatar

Joerg Baumgarten

Bayer

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Joerg Baumgarten is active.

Explore More

Publication

Featured researches published by Joerg Baumgarten.

Journal of Medicinal Chemistry | 2001

Design and optimization of 20-O-linked camptothecin glycoconjugates as anticancer agents.

Hans-Georg Lerchen; Joerg Baumgarten; Karsten Von Dem Bruch; Thomas Lehmann; Michael Sperzel; and Grazyna Kempka; Heinz-Herbert Fiebig

Angewandte Chemie | 1999

Lectin-Mediated Drug Targeting: Discrimination of Carbohydrate-Mediated Cellular Uptake between Tumor and Liver Cells with Neoglycoconjugates Carrying Fucose Epitopes Regioselectively Modified in the 3-Position.

Hans-Georg Lerchen; Joerg Baumgarten; Norbert Piel; Victoria Kolb-Bachofen

Archive | 1999

Cyclopentabenzofuran derivatives and their use

Walter Guarnieri; Thomas Jaetsch; Andreas Schoop; Joerg Baumgarten; Axel Kretschmer; Horst-Peter Antonicek

Angewandte Chemie | 1999

Lectin‐vermitteltes Drug‐Targeting: Diskriminierung zwischen der Kohlenhydrat‐vermittelten Aufnahme von Neoglycokonjugaten, die in 3‐Position modifizierte Fucose‐Epitope tragen, in Tumor‐ oder Leberzellen

Hans-Georg Lerchen; Joerg Baumgarten; Norbert Piel; Victoria Kolb-Bachofen

Archive | 1991

Anti-sense-RNA expression vectors - contain hybrid promoter sequences and viral DNA sequences i.e. HIV, in anti-sense direction, useful in prodn. of HIV-resistant cells

Axel Kretschmer; Horst-Peter Antonicek; Joerg Baumgarten; Antonius Dr Loebberding; Burkhard Mielke; Wolfgang Springer; Udo Stropp; Mark-Michael Dr. Struck; Lothar Biesert; Helga Ruebsamen-Waigmann; Hary Suhartono

Archive | 2001

Use of galiella lactone

Joerg Baumgarten; Marcus Weidler; Gerhard Erkel; H. Anke; Timm Anke

Archive | 2001

Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units

Hans-Georg Lerchen; Joerg Baumgarten; Oswald Lockhoff

Archive | 2002

Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units

Hans-Georg Lerchen; Joerg Baumgarten; Oswald Lockhoff; Markus Albers; Andreas Schoop

Archive | 2001

Cytostatic-glycoconjugates having specifically cleavable linking units

Hans-Georg Lerchen; Joerg Baumgarten; Oswald Lockhoff

Archive | 2000

Integrin-vermittelte arzneimittel-zielrichtung Integrin-mediated drug-target direction

Hans-Georg Lerchen; Joerg Baumgarten; Ulf Brueggemeier; Markus Albers; Andreas Schoop; Thomas-J Schulze

Explore More

Collaboration

Dive into the Joerg Baumgarten's collaboration.

Top Co-Authors
Avatar

Hans-Georg Lerchen

Bayer

View shared research outputs
Top Co-Authors
Avatar

Axel Kretschmer

Bayer

View shared research outputs
Top Co-Authors
Avatar

Horst-Peter Antonicek

Bayer

View shared research outputs
Top Co-Authors
Avatar

Michael Sperzel

Bayer

View shared research outputs
Top Co-Authors
Avatar

Udo Stropp

Bayer

View shared research outputs
Top Co-Authors
Avatar

Karsten Von Dem Bruch

Bayer

View shared research outputs
Top Co-Authors
Avatar

Wolfgang Springer

Bayer

View shared research outputs
Top Co-Authors
Avatar

Norbert Piel

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Andreas Schoop

Bayer

View shared research outputs
Top Co-Authors
Avatar

Antonius Dr Loebberding

Bayer

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge